Melissa Cushing, M.D.

Melissa Cushing

Dr. Cushing received an M.D. from Georgetown University School of Medicine in 2001. She completed clinical pathology residency at Emory University School of Medicine in 2005. She finished her training with a fellowship in Transfusion Medicine and Cellular Therapy at the Johns Hopkins School of Medicine in 2006. Dr. Cushing joined the faculty at Weill Cornell Medical College in October 2006. She is Director of Transfusion Medicine and Cellular Therapy.


Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.

* indicates this physician is no longer accepting new patients with this insurance plan.

  • AETNA [Medicare]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Plus - Amerigroup [CHP]
  • Health Plus - Amerigroup
  • Health Republic
  • Medicare
  • Oscar
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Freedom]
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]


Peer Reviewed Articles

Simon MS, Leff JA, Pandya A, Cushing MM, Shaz BH, Calfee DP, Schackman BR, Mushlin AI. Cost-effectiveness of Blood Donor Screening for Babesia microti in Endemic Regions of the United States. Transfusion. 2013 Nov 19 (epub ahead of print)

Villa C, Shore T, Van Besien K, Cushing MM. Addition of plerixafor to mobilization regimens in autologous peripheral blood stem cell transplants does not affect the correlation of pre-harvest hematopoietic precursor cell (HPC) enumeration with first harvest CD34+stem cell yield.  Biol Blood Marrow Transplant. 2012;18:1867-75.

Kawaguchi K, Mark T, Friedman K, Cushing MM. Factor VIII/Von Willebrand Factor Concentrate Therapy for Ventricular Assist Device-Associated Acquired Von Willebrand Disease.  Transfusion. 2012;52:1535-41.

Arinsburg SA, Skerrett DL, Friedman M, Cushing MM.  A Survey to Assess Transfusion Medicine Education Needs for Clinicians.  Transfus Med. 2012;22:44-9.

Arinsburg SA, Skerrett DL, Karp JL, King K, Padmanabhan P, Jhang J, Schwartz J, Ness P, Cushing MM. Exclusion of female plasma donors significantly reduces transfusion-related acute lung injury.  Transfusion. 2012;52:946-52.

Michael R. Jacobs, Daniel Smith, W. Andrew Heaton, Nicole D. Zantek, Caryn E. Good, and PGD Study Group (Cushing MM, member).  Detection of bacterial contamination in prestorage culture negative apheresis platelets on day of issue with the PGD test.  Transfusion. 2011;51:2573-82.

Arinsburg SA, Skerrett DL, Giardina PJ, Cushing MM. The Significance of a Positive Direct Antiglobulin Test in Thalassemic Patients.  Immunohematology. 2010;26:87-91.

Tormey CA, Peddinghaus ME, Erickson M, King K, Cushing MM, Bill J, Goodrich T, Snyder EL.  Improved Plasma Removal Efficiency for Therapeutic Plasma Exchange Using a New Apheresis Platform.  Transfusion. 2010; 50:471-7.

Webber BA, Cushing MM, Li S. Prognostic Significance of Flow Cytometric Immunophenotyping in Acute Myeloid Leukemia. Int J Clin Exp Pathol. 2008. 1(2):124-133.

Cushing MM, Brat DJ, Mosunjac MI, et al. Fatal West Nile virus encephalitis in a renal transplant recipient. AJCP 2004; 121(1):26-31.

Von Stebut E, Belkaid Y, Nguyen BV, Cushing M, Sacks DL, Udey MC. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. Eur J Immunol 2000; 30(12):3498-506.

Editorials, Case Reports and Letters to the Editor

Rennert H, Leonard DG, Cushing M, Azurin C, Shore T. Avoiding pitfalls in bone marrow engraftment analysis: a case study highlighting the weakness of using buccal cells for determining a patient’s constitutional genotype after hematopoietic stem cell transplantation. Cytotherapy. 2013;15:391-5

van Besien K, Shore T, Cushing M.  Peripheral-blood versus bone marrow stem cell. N Engl J Med. 2013;368:287-8.

Cushing MM, Shaz B. Transfusion-transmitted babesiosis: achieving successful mitigation while balancing cost and donor loss. Transfusion. 2012;52:1404-7.

Cushing, MM, Degtyaryova D, Lomas-Francis C.  The role of plasmapheresis in the multimodal treatment of anti-Pr cold agglutinin disease.  Transfusion. 2010;50: 2100-1.

Cushing MM, Brat DJ, Mosunjac MI, et al.  Fatal West Nile virus encephalitis in a renal transplant recipient.  AJCP. 2004;121:26-31.